The weight management share is projected to decline to 55% by 2035 as cardiovascular risk anchored indications grow to 45% of the market
Some patients who plateau on semaglutide alone respond well to tirzepatide or PlexusDx's GLP-Squared combination (semaglutide plus tirzepatide), at $289/mo month-to-month, or from $249/mo on the 6-month plan for the injection
However, that change might not be reflected in the patient's chart, making it an important occurrence worth further understanding
Drug interactions can occur
T2DXX highlighted that current health care systems, at the individual and government level, are in need of improvement to address the needs of diabetes patients and improve overall health
It shows a high concentration in cells central to repair: platelets, macrophages, and endothelial cells [6]